Okusha Yuka, Eguchi Takanori, Tran Manh T, Sogawa Chiharu, Yoshida Kaya, Itagaki Mami, Taha Eman A, Ono Kisho, Aoyama Eriko, Okamura Hirohiko, Kozaki Ken-Ichi, Calderwood Stuart K, Takigawa Masaharu, Okamoto Kuniaki
Department of Dental Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8525, Japan.
Division of Molecular and Cellular Biology, Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Cancers (Basel). 2020 Apr 4;12(4):881. doi: 10.3390/cancers12040881.
Matrix metalloproteinase 3 (MMP3) plays multiple roles in extracellular proteolysis as well as intracellular transcription, prompting a new definition of moonlighting metalloproteinase (MMP), according to a definition of protein moonlighting (or gene sharing), a phenomenon by which a protein can perform more than one function. Indeed, connective tissue growth factor (CTGF, aka cellular communication network factor 2 (CCN2)) is transcriptionally induced as well as cleaved by MMP3. Moreover, several members of the MMP family have been found within tumor-derived extracellular vesicles (EVs). We here investigated the roles of MMP3-rich EVs in tumor progression, molecular transmission, and gene regulation. EVs derived from a rapidly metastatic cancer cell line (LuM1) were enriched in MMP3 and a C-terminal half fragment of CCN2/CTGF. MMP3-rich, LuM1-derived EVs were disseminated to multiple organs through body fluid and were pro-tumorigenic in an allograft mouse model, which prompted us to define LuM1-EVs as oncosomes in the present study. Oncosome-derived MMP3 was transferred into recipient cell nuclei and thereby trans-activated the promoter, and induced CCN2/CTGF production in vitro. TRENDIC and other cis-elements in the promoter were essential for the oncosomal responsivity. The CRISPR/Cas9-mediated knockout of MMP3 showed significant anti-tumor effects such as the inhibition of migration and invasion of tumor cells, and a reduction in CCN2/CTGF promoter activity and fragmentations in vitro. A high expression level of MMP3 or CCN2/CTGF mRNA was prognostic and unfavorable in particular types of cancers including head and neck, lung, pancreatic, cervical, stomach, and urothelial cancers. These data newly demonstrate that oncogenic EVs-derived MMP is a transmissive trans-activator for the cellular communication network gene and promotes tumorigenesis at distant sites.
基质金属蛋白酶3(MMP3)在细胞外蛋白水解以及细胞内转录中发挥多种作用,这促使人们对兼职金属蛋白酶(MMP)有了新的定义,根据蛋白质兼职(或基因共享)的定义,即一种蛋白质可以执行多种功能的现象。事实上,结缔组织生长因子(CTGF,又称细胞通讯网络因子2(CCN2))可被MMP3转录诱导并切割。此外,在肿瘤来源的细胞外囊泡(EVs)中发现了MMP家族的几个成员。我们在此研究了富含MMP3的EVs在肿瘤进展、分子传递和基因调控中的作用。源自快速转移癌细胞系(LuM1)的EVs富含MMP3和CCN2/CTGF的C末端半片段。富含MMP3的LuM1来源的EVs通过体液扩散到多个器官,并且在同种异体移植小鼠模型中具有促肿瘤作用,这促使我们在本研究中将LuM1-EVs定义为癌小体。癌小体来源的MMP3被转移到受体细胞核中,从而反式激活启动子,并在体外诱导CCN2/CTGF的产生。启动子中的TRENDIC和其他顺式元件对于癌小体的反应性至关重要。CRISPR/Cas9介导的MMP3基因敲除显示出显著的抗肿瘤作用,如抑制肿瘤细胞的迁移和侵袭,以及降低体外CCN2/CTGF启动子活性和片段化。MMP3或CCN2/CTGF mRNA的高表达水平在包括头颈癌、肺癌、胰腺癌、宫颈癌、胃癌和尿路上皮癌在内的特定类型癌症中具有预后意义且不利。这些数据首次表明,致癌性EVs来源的MMP是细胞通讯网络基因的传递性反式激活因子,并促进远处部位的肿瘤发生。